Abstract
Acute kidney injury (AKI) is a common complication after coronary angiography. Early biomarkers of this disease are needed since increase in serum creatinine levels is a late marker. To assess the usefulness of urinary kidney injury molecule-1 (uKIM-1), neutrophil gelatinase-associated lipocalin (uNGAL) and liver-type fatty acid-binding protein (uL-FABP) for early detection of AKI in these patients, comparing their performance with another group of cardiac surgery patients. Biomarkers were measured in 193 patients, 12 h after intervention. In the ROC analysis, AUC for KIM-1, NGAL and L-FABP was 0.713, 0.958 and 0.642, respectively, in the coronary angiography group, and 0.716, 0.916 and 0.743 in the cardiac surgery group. Urinary KIM-1 12 h after intervention is predictive of AKI in adult patients undergoing coronary angiography, but NGAL shows higher sensitivity and specificity. L-FABP provides inferior discrimination for AKI than KIM-1 or NGAL in contrast to its performance after cardiac surgery. This is the first study showing the predictive capacity of KIM-1 for AKI after coronary angiography. Further studies are still needed to answer relevant questions about the clinical utility of biomarkers for AKI in different clinical settings.
Similar content being viewed by others
References
Carbonell N, Blasco M, Sanjuán R, Pérez-Sancho E, Sanchis J, Insa L, Bodí V, Núñez J, García-Ramón R, Miguel A (2007) Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. Int J Cardiol 115:57–62
McCullough PA (2008) Contrast-induced acute kidney injury. J Am Coll Cardiol 51:1419–1428
Marenzi G, De Metrio M, Rubino M, Lauri G, Cavallero A (2010) Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention. Am Heart J 160:1170–1177
Matejka J, Varvarovsky I, Vojtisek P, Herman A, Rozsival V, Borkova V, Kvasnicka J (2010) Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease. Heart Vessels 25:536–542
Ogita M, Sakakura K, Nakamura T, Funayama H, Wada H, Naito R, Sugawara Y, Kubo N, Ako J, Momomura S (2012) Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention. Heart Vessels 27:460–467
Rosner MH, Okusa MD (2006) Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1:19–32
Del Duca D, Iqbal S, Rahme E, Goldberg P, De Varennes B (2007) Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg 84:1264–1271
Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC (2009) Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 119:495–502
Mariscalco G, Nicolini F, Scannapieco A, Gherli R, Serraino F, Dominici C, Renzulli A, Gherli T, Sala A, Beghi C (2013) Acute kidney injury after composite valve-graft replacement for ascending aorta aneurysms. Heart Vessels 28:229–236
Lassnigg A, Schmidlin D, Mouhieddine M (2004) Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597–1605
Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function. Measured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483
Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543
Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231–1238
Haase M, Bellomo R, Devarajan P, Schlattmann P, Anja Haase-Fielitz A, the NGAL Meta-analysis Investigator Group (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54:1012–1024
McIlroy DR, Wagener G, Lee HT (2010) Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 5:211–219
Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim RW, Koyner JL, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD, TRIBE-AKI Consortium (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22:1737–1747
Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX, TRIBE-AKI Consortium (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22:1748–1757
Torregrosa I, Montoliu C, Urios A, Elmlili N, Puchades MJ, Solís MA, Sanjuán R, Blasco ML, Ramos C, Tomás P, Ribes J, Carratalá A, Juan I, Miguel A (2012) Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure. Nefrologia 32:44–52
Liu S, Che M, Xue S, Xie B, Zhu M, Lu R, Zhang W, Qian J, Yan Y (2013) Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients. Biomarkers 18:95–101
Bachorzewska-Gajewska H, Poniatowski B, Dobrycki S (2009) NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Adv Med Sci 54:221–224
Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S (2009) Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and normal serum creatinine. Ren Fail 31:910–919
Tasanarong A, Hutayanon P, Piyayotai D (2013) Urinary neutrophil gelatinase-associated lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. BMC Nephrol 14:270
Parikh CR, Thiessen-Philbrook H, Garg AX, Kadiyala D, Shlipak MG, Koyner JL, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Coca SG, TRIBE-AKI Consortium (2013) Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 8:1079–1088
Shao X, Tian L, Xu W, Zhang Z, Wang C, Qi C, Ni Z, Mou S (2014) Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis. PLoS ONE 9:e84131
Susantitaphong P, Siribamrungwong M, Doi K, Noiri E, Terrin N, Jaber BL (2013) Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis. Am J Kidney Dis 61:430–439
Katoh H, Nozue T, Kimura Y, Nakata S, Iwaki T, Kawano M, Kawashiri MA, Michishita I, Yamagishi M (2014) Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium. Heart Vessels 29:191–197
Fujita D, Takahashi M, Doi K, Abe M, Tazaki J, Kiyosue A, Myojo M, Ando J, Fujita H, Noiri E, Sugaya T, Hirata Y, Komuro I (2014) Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease. Heart Vessels. doi:10.1007/s00380-014-0484-9
Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W (2013) Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 28:254–273
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, the ADQI Workgroup (2004) Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 8:R204–R212
World Medical Association (1997) Declaration of Helsinki: recommendations guiding medical physicians in biomedical research involving human subjects. JAMA 277:925–926
Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S (2008) Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Nephrology (Carlton) 13:153–156
Przybylowski P, Malyszko J, Malyszko J (2010) Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients. Med Sci Monit 16:440–444
Martensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensiv Care Med 36:1333–1340
Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E (2010) Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5:2154–2165
Ma X, Zhang BR, Li DT (2011) Value of urinary kidney injury molecule-1 protein in early diagnosis of radiocontrast- induced nephropathy in rats. Nan Fang Yi Ke Da Xue Xue Bao 31:357–360
Ralib AM, Pickering JW, Shaw GM, Devarajan P, Edelstein CL, Bonventre JV, Endre ZH (2012) Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 23:322–333
Singer E, Elger A, Elitok S, Kettritz R, Nickolas TL, Barasch J, Luft FC, Schmidt-Ott KM (2011) Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int 80:405–414
Doi K, Katagiri D, Negishi K, Hasegawa S, Hamasaki Y, Fujita T, Matsubara T, Ishii T, Yahagi N, Sugaya T, Noiri E (2012) Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int 82:1114–1120
Nejat M, Pickering JW, Devarajan P, Bonventre JV, Edelstein CL, Walker RJ, Endre ZH (2012) Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 81:1254–1262
Acknowledgments
This research was supported by grants from Ministerio de Ciencia e Innovacion of Spain [PS09/00806 (CM), PI10/01434 (AM) and PI12/00884 (CM)] co-financing by the European Fund for Regional Development (FEDER); from Consellería de Educación de la Generalitat Valenciana (ACOMP/2009/191 and ACOMP/2012/056 to CM) and Sanitat (AP-028/10, AP-087/11 to CM). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Torregrosa, I., Montoliu, C., Urios, A. et al. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography. Heart Vessels 30, 703–711 (2015). https://doi.org/10.1007/s00380-014-0538-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-014-0538-z